Loading...

Association of Serum Osteoprotegerin Levels with Bone Loss in Chronic Kidney Disease: Insights from the KNOW-CKD Study

Osteoprotegerin, a potent osteoclast activation inhibitor, decreases bone resorption and positively affects bone mineral density. This study examined the association between serum osteoprotegerin levels and bone loss in patients with chronic kidney disease, a condition associated with increased risk...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:PLoS One
Main Authors: Kim, Chang Seong, Bae, Eun Hui, Ma, Seong Kwon, Han, Seung Hyeok, Choi, Kyu Hun, Lee, Joongyub, Chae, Dong Wan, Oh, Kook-Hwan, Ahn, Curie, Kim, Soo Wan
Format: Artigo
Sprog:Inglês
Udgivet: Public Library of Science 2016
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5113973/
https://ncbi.nlm.nih.gov/pubmed/27855207
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0166792
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!